Literature DB >> 22709515

Pathogenesis of influenza virus infections: the good, the bad and the ugly.

T Kuiken1, B Riteau, R A M Fouchier, G F Rimmelzwaan.   

Abstract

The clinical outcome of different influenza virus infections ranges from subclinical upper respiratory tract disease to fatal lower respiratory tract disease. An important determinant in the pathogenesis of these diseases is the tissue tropism of the influenza virus. Furthermore, virulence is often correlated with virus replication and is regulated by multiple virus genes. Host defense against virus infection consists of both innate and adaptive immune responses. However, excessive or dysbalanced immune response may result in lung tissue damage, reduced respiratory capacity, and severe disease or even death. By interdisciplinary efforts to better understand the intricate interaction between virus, tissue, and immune response, we may be able to find new ways to improve the outcome of influenza virus infections.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22709515     DOI: 10.1016/j.coviro.2012.02.013

Source DB:  PubMed          Journal:  Curr Opin Virol        ISSN: 1879-6257            Impact factor:   7.090


  70 in total

1.  Novel avian-origin influenza A (H7N9) virus attaches to epithelium in both upper and lower respiratory tract of humans.

Authors:  Debby van Riel; Lonneke M E Leijten; Miranda de Graaf; Jurre Y Siegers; Kirsty R Short; Monique I J Spronken; Eefje J A Schrauwen; Ron A M Fouchier; Albert D M E Osterhaus; Thijs Kuiken
Journal:  Am J Pathol       Date:  2013-09-10       Impact factor: 4.307

2.  Intranasal Introduction of Fc-Fused Interleukin-7 Provides Long-Lasting Prophylaxis against Lethal Influenza Virus Infection.

Authors:  Moon Cheol Kang; Dong-Hoon Choi; Young Woo Choi; Seong Jeong Park; Hong Namkoong; Ki Seok Park; So-Shin Ahn; Charles D Surh; Sun-Woo Yoon; Doo-Jin Kim; Jung-ah Choi; Yunji Park; Young Chul Sung; Seung-Woo Lee
Journal:  J Virol       Date:  2015-12-09       Impact factor: 5.103

Review 3.  The inflammatory response triggered by Influenza virus: a two edged sword.

Authors:  Luciana P Tavares; Mauro M Teixeira; Cristiana C Garcia
Journal:  Inflamm Res       Date:  2016-10-15       Impact factor: 4.575

4.  Constitutively Expressed IFITM3 Protein in Human Endothelial Cells Poses an Early Infection Block to Human Influenza Viruses.

Authors:  Xiangjie Sun; Hui Zeng; Amrita Kumar; Jessica A Belser; Taronna R Maines; Terrence M Tumpey
Journal:  J Virol       Date:  2016-11-28       Impact factor: 5.103

Review 5.  Switch from protective to adverse inflammation during influenza: viral determinants and hemostasis are caught as culprits.

Authors:  Fatma Berri; Vuong Ba Lê; Martine Jandrot-Perrus; Bruno Lina; Béatrice Riteau
Journal:  Cell Mol Life Sci       Date:  2013-10-04       Impact factor: 9.261

6.  Syndecan-1 Attenuates Lung Injury during Influenza Infection by Potentiating c-Met Signaling to Suppress Epithelial Apoptosis.

Authors:  Rena Brauer; Lingyin Ge; Saundra Y Schlesinger; Timothy P Birkland; Ying Huang; Tanyalak Parimon; Vivian Lee; Bonnie L McKinney; John K McGuire; William C Parks; Peter Chen
Journal:  Am J Respir Crit Care Med       Date:  2016-08-01       Impact factor: 21.405

7.  Combination activity of neuraminidase inhibitor oseltamivir and α-tocopherol in influenza virus A (H3N2) infection in mice.

Authors:  Angel S Galabov; Milka Mileva; Lora Simeonova; Galina Gegova
Journal:  Antivir Chem Chemother       Date:  2016-06-24

8.  Avian influenza H5 hemagglutinin binds with high avidity to sialic acid on different O-linked core structures on mucin-type fusion proteins.

Authors:  Stefan Gaunitz; Jining Liu; Anki Nilsson; Niclas Karlsson; Jan Holgersson
Journal:  Glycoconj J       Date:  2014-02       Impact factor: 2.916

9.  PAR1 contributes to influenza A virus pathogenicity in mice.

Authors:  Khaled Khoufache; Fatma Berri; Wolfgang Nacken; Annette B Vogel; Marie Delenne; Eric Camerer; Shaun R Coughlin; Peter Carmeliet; Bruno Lina; Guus F Rimmelzwaan; Oliver Planz; Stephan Ludwig; Béatrice Riteau
Journal:  J Clin Invest       Date:  2012-12-03       Impact factor: 14.808

10.  Annexin V incorporated into influenza virus particles inhibits gamma interferon signaling and promotes viral replication.

Authors:  Fatma Berri; Ghina Haffar; Vuong Ba Lê; Anne Sadewasser; Katharina Paki; Bruno Lina; Thorsten Wolff; Béatrice Riteau
Journal:  J Virol       Date:  2014-07-16       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.